CYTK:NASDAQ
Cytokinetics, Inc.
US$73,68
arrow_downward
-4,01%(-3,08) 1D
US$72,40
arrow_downward
-1,73% (-1,28)bedtimeAfter hours
Closed: 1 ມິ.ຖ., 16 ໂມງ 0 ນາທີ 01 ວິນາທີ GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for CYTK...
Open
US$76,09
High
US$76,48
Low
US$73,18
Mkt. cap
໙,໙໙ ຕື້
Avg. vol.
໒,໙໘ ລ້ານ
Volume
໑,໖໖ ລ້ານ
52-wk high
US$80,20
52-wk low
US$30,56
EPS
US$-6,84
Beta
໐,໓໘
Shares outstanding
໑໒໔,໔໓ ລ້ານ
No. of employees
໖໗໓
Open
US$76,09
High
US$76,48
Low
US$73,18
Mkt. cap
໙,໙໙ ຕື້
Avg. vol.
໒,໙໘ ລ້ານ
Volume
໑,໖໖ ລ້ານ
52-wk high
US$80,20
52-wk low
US$30,56
EPS
US$-6,84
Beta
໐,໓໘
Shares outstanding
໑໒໔,໔໓ ລ້ານ
No. of employees
໖໗໓
News stories
From sources across the web
GuruFocus
·
1 ຊົ່ວໂມງກ່ອນ
Insider Sell Alert: Kaye Edward M. MD Sells Shares of Cytokinetics Inc (CYTK)
Investing.com Nigeria
·
1 ຊົ່ວໂມງກ່ອນ
Cytokinetics EVP Andrew Callos sells $1.11m in stock By Investing.com
Investing.com Nigeria
·
1 ຊົ່ວໂມງກ່ອນ
Cytokinetics director Edward Kaye sells $223,171 in shares By Investing.com
Stock Titan
·
5 ຊົ່ວໂມງກ່ອນ
[144] CYTOKINETICS INC SEC Filing
Profile
Cytokinetics, Incorporated, is a biopharmaceutical company based in South San Francisco, California, that develops muscle activators and muscle inhibitors as potential treatments for people with diseases characterized by impaired or declining muscle function. Wikipedia
About Cytokinetics, Inc.
CEORobert I. Blum | Robert I. Blum
Employees673
Founded1997
HeadquartersSouth San Francisco, ແຄລິຟໍເນຍ, ສະຫະລັດ
SectorBiotechnology
Websitecytokinetics.com
AI content may include mistakes. Learn more